Autolus Therapeutics PLC (AUTL)
4.19
+0.08
(+1.95%)
USD |
NASDAQ |
May 03, 16:00
4.185
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Total Liabilities (Quarterly): 263.91M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 263.91M |
| September 30, 2023 | 225.58M |
| June 30, 2023 | 221.66M |
| March 31, 2023 | 193.05M |
| December 31, 2022 | 191.60M |
| September 30, 2022 | 102.68M |
| June 30, 2022 | 99.46M |
| March 31, 2022 | 92.85M |
| December 31, 2021 | 92.24M |
| September 30, 2021 | 51.91M |
| June 30, 2021 | 46.97M |
| Date | Value |
|---|---|
| March 31, 2021 | 50.18M |
| December 31, 2020 | 84.20M |
| September 30, 2020 | 80.27M |
| June 30, 2020 | 51.60M |
| March 31, 2020 | 50.19M |
| December 31, 2019 | 48.69M |
| September 30, 2019 | 45.00M |
| June 30, 2019 | 47.92M |
| March 31, 2019 | 46.47M |
| March 31, 2018 | 16.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
45.00M
Minimum
Sep 2019
263.91M
Maximum
Dec 2023
107.37M
Average
84.20M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 243.10M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| NuCana PLC | 16.46M |
| TC BioPharm (Holdings) PLC | 7.957M |
| Mereo BioPharma Group PLC | 15.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 375.38M |
| Shareholders Equity (Quarterly) | 111.47M |